Generali Investments Management Co LLC Has $1.30 Million Position in Colgate-Palmolive Company $CL

Generali Investments Management Co LLC lessened its position in Colgate-Palmolive Company (NYSE:CL) by 14.7% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 14,361 shares of the company’s stock after selling 2,480 shares during the period. Generali Investments Management Co LLC’s holdings in Colgate-Palmolive were worth $1,304,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently modified their holdings of the company. Vanguard Group Inc. grew its holdings in Colgate-Palmolive by 0.6% during the first quarter. Vanguard Group Inc. now owns 81,758,257 shares of the company’s stock worth $7,660,749,000 after purchasing an additional 455,198 shares during the period. Price T Rowe Associates Inc. MD lifted its position in shares of Colgate-Palmolive by 18.3% in the first quarter. Price T Rowe Associates Inc. MD now owns 34,009,078 shares of the company’s stock valued at $3,186,651,000 after buying an additional 5,269,140 shares during the last quarter. Goldman Sachs Group Inc. boosted its stake in shares of Colgate-Palmolive by 34.5% during the 1st quarter. Goldman Sachs Group Inc. now owns 7,980,387 shares of the company’s stock worth $747,762,000 after acquiring an additional 2,045,191 shares during the period. Deutsche Bank AG increased its holdings in shares of Colgate-Palmolive by 3.7% during the 1st quarter. Deutsche Bank AG now owns 7,176,598 shares of the company’s stock worth $672,447,000 after acquiring an additional 253,604 shares during the last quarter. Finally, Ameriprise Financial Inc. raised its stake in Colgate-Palmolive by 2.6% in the 1st quarter. Ameriprise Financial Inc. now owns 6,976,654 shares of the company’s stock valued at $653,761,000 after acquiring an additional 177,833 shares during the period. 80.41% of the stock is owned by institutional investors.

Colgate-Palmolive Stock Performance

NYSE CL opened at $78.01 on Friday. The firm has a 50-day moving average price of $79.18 and a two-hundred day moving average price of $85.21. Colgate-Palmolive Company has a 12-month low of $74.54 and a 12-month high of $100.18. The company has a market capitalization of $62.88 billion, a P/E ratio of 21.91, a P/E/G ratio of 4.44 and a beta of 0.35. The company has a quick ratio of 0.57, a current ratio of 0.89 and a debt-to-equity ratio of 6.79.

Colgate-Palmolive (NYSE:CL) last announced its earnings results on Friday, October 31st. The company reported $0.91 EPS for the quarter, topping the consensus estimate of $0.89 by $0.02. The company had revenue of $5.13 billion for the quarter, compared to analysts’ expectations of $5.17 billion. Colgate-Palmolive had a net margin of 14.55% and a return on equity of 377.63%. The business’s revenue for the quarter was up 1.9% on a year-over-year basis. During the same period last year, the firm earned $0.91 earnings per share. Analysts anticipate that Colgate-Palmolive Company will post 3.75 earnings per share for the current year.

Colgate-Palmolive Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, November 14th. Stockholders of record on Friday, October 17th were given a dividend of $0.52 per share. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.7%. The ex-dividend date was Friday, October 17th. Colgate-Palmolive’s dividend payout ratio is presently 58.26%.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on CL shares. Barclays reduced their price objective on shares of Colgate-Palmolive from $82.00 to $80.00 and set an “equal weight” rating for the company in a research report on Tuesday, November 4th. Wells Fargo & Company reduced their target price on shares of Colgate-Palmolive from $80.00 to $77.00 and set an “underweight” rating for the company in a report on Monday, November 3rd. Morgan Stanley lowered their price target on shares of Colgate-Palmolive from $96.00 to $87.00 and set an “overweight” rating on the stock in a report on Monday, November 3rd. The Goldman Sachs Group reduced their price objective on Colgate-Palmolive from $106.00 to $91.00 and set a “buy” rating for the company in a report on Thursday, October 2nd. Finally, UBS Group decreased their target price on Colgate-Palmolive from $92.00 to $90.00 and set a “buy” rating on the stock in a research report on Monday, November 3rd. Nine research analysts have rated the stock with a Buy rating, five have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, Colgate-Palmolive presently has a consensus rating of “Moderate Buy” and an average target price of $89.87.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.